Activation of adenosine receptors exerts important effects in the heart. The presence of a functional adenosine A3 receptor on the heart cell suggests a novel cardiac function for this receptor. Using cultured cardiac atrial and ventricular cells as models, the overall objective of the present proposal is to investigate the signaling mechanism, regulation, and function of the adenosine A3 receptor and to investigate the role of A1 and A3 receptors and the underlying mechanisms in preconditioning of cardiac myocytes. Specifically, the proposal will 1) carry out pharmacological characterization of the cardiac A3 receptor, 2) investigate the potential effectors, such as phospholipases, adenylyl cyclase and KATP channel, to which the A3 receptor is coupled, and 3) characterize desensitization of A3 receptor-coupled effectors. Because A1 and A3 receptors may have different signaling mechanisms and functions and may exhibit differential desensitization by adenosine agonist, parallel studies on the A1 receptor will be performed for direct comparison. Using a novel cardiac ventricular myocyte model of preconditioning, the proposal will further 4) investigate the role of A1 and A3 receptors in initiating and mediating the protective effect of preconditioning, and 5) study the mechanism by which activation of each receptor induces preconditioning and determine the role of protein kinase C and KATP channel in mediating this protective phenomenon. Moreover, atrial myocytes express only the A1 receptor and exhibit characteristics of preconditioning similar to the characteristics of A1 receptor-mediated preconditioning in the ventricular myocytes. Thus, atrial myocytes represent a useful """"""""null"""""""" myocyte model for the A3 receptor and atrial myocytes transfected with A3 receptor cDNA will be used to further test the function and signaling mechanism of A3 receptor during preconditioning. The proposal should yield important and new information on the cardiac actions and signaling mechanisms of adenosine and its receptor subtypes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL048225-04A2
Application #
2465728
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1993-09-01
Project End
2002-08-31
Budget Start
1997-09-30
Budget End
1998-08-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Verma, Rajkumar; Cronin, Chunxia G; Hudobenko, Jacob et al. (2017) Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke. Brain Behav Immun 66:302-312
Yang, Ronghua; Beqiri, Dardan; Shen, Jian-Bing et al. (2015) P2X4 receptor-eNOS signaling pathway in cardiac myocytes as a novel protective mechanism in heart failure. Comput Struct Biotechnol J 13:1-7
Yang, Tiehong; Shen, Jian-bing; Yang, Ronghua et al. (2014) Novel protective role of endogenous cardiac myocyte P2X4 receptors in heart failure. Circ Heart Fail 7:510-8
Shen, Jian-Bing; Yang, Ronghua; Pappano, Achilles et al. (2014) Cardiac P2X purinergic receptors as a new pathway for increasing Na? entry in cardiac myocytes. Am J Physiol Heart Circ Physiol 307:H1469-77
Pereira, Flavia E; Cronin, Chunxia; Ghosh, Mallika et al. (2013) CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in mice. Cardiovasc Res 100:74-83
Zhou, Siyuan; Yang, Tiehong; Jacobson, Kenneth A et al. (2013) The therapeutic effect of 2-cyclohexylthio-AMP in heart failure. J Cardiovasc Pharmacol 61:553-9
Kumar, T Santhosh; Yang, Tiehong; Mishra, Shilpi et al. (2013) 5'-Phosphate and 5'-phosphonate ester derivatives of (N)-methanocarba adenosine with in vivo cardioprotective activity. J Med Chem 56:902-14
Yang, Ronghua; Liang, Bruce T (2012) Cardiac P2X(4) receptors: targets in ischemia and heart failure? Circ Res 111:397-401
Zhou, Si-Yuan; Mamdani, Mohammed; Qanud, Khaled et al. (2010) Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptors. J Pharmacol Exp Ther 333:920-8
Kumar, T Santhosh; Zhou, Si-Yuan; Joshi, Bhalchandra V et al. (2010) Structure-activity relationship of (N)-Methanocarba phosphonate analogues of 5'-AMP as cardioprotective agents acting through a cardiac P2X receptor. J Med Chem 53:2562-76

Showing the most recent 10 out of 41 publications